This summary was created by AI, based on 1 opinions in the last 12 months.
Treatment.com AI (TRUE-CN) is developing a medical language model that uses AI to make medical processes more efficient. It has potential applications for doctors, 911 dispatchers, nursing centers, and medical office receptionists. The company is debt-free and has already signed a significant deal with the University of Edinburgh, with more deals expected to bring about positive cash flow. Overall, it appears to have a promising future in the medical AI field.
Treatment.com AI is a Canadian stock, trading under the symbol TRUE-CN on the Canadian Securities Exchange (). It is usually referred to as or TRUE-CN
In the last year, there was no coverage of Treatment.com AI published on Stockchase.
Treatment.com AI was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Treatment.com AI.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Treatment.com AI published on Stockchase.
On 2025-01-14, Treatment.com AI (TRUE-CN) stock closed at a price of $0.61.
Using AI to make things more efficient. Medical language model, using a finite universe of only medical data. Helps doctors to diagnose issues. Can be used by medical office receptionists, doctors, 911 dispatchers, nursing centres. Debt free. Deal signed with University of Edinburgh. A few more deals should make them cashflow positive.